ArticleRheumatology international2024

Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.

Lisa Schapink et al.PubMed ↗Publisher ↗

No numbers read from the abstract.